Comprehensive Molecular Tumor Analysis with Alacris Theranostics
Warning: Attempt to read property "state_province" on int in /sites/staging.digitalinsights.supremeclients.com/files/wp-content/plugins/the-events-calendar/src/views/v2/list/event/venue.php on line 27
Warning: Attempt to read property "state" on int in /sites/staging.digitalinsights.supremeclients.com/files/wp-content/plugins/the-events-calendar/src/views/v2/list/event/venue.php on line 27
Warning: Attempt to read property "province" on int in /sites/staging.digitalinsights.supremeclients.com/files/wp-content/plugins/the-events-calendar/src/views/v2/list/event/venue.php on line 27
Warning: Attempt to read property "address" on int in /sites/staging.digitalinsights.supremeclients.com/files/wp-content/plugins/the-events-calendar/src/views/v2/list/event/venue.php on line 28
Warning: Attempt to read property "address" on int in /sites/staging.digitalinsights.supremeclients.com/files/wp-content/plugins/the-events-calendar/src/views/v2/list/event/venue.php on line 28
Warning: Attempt to read property "post_title" on int in /sites/staging.digitalinsights.supremeclients.com/files/wp-content/plugins/the-events-calendar/src/views/v2/list/event/venue.php on line 32
Join Dr. Marie-Laure Yaspo, Co-Founder and Chief Scientific Officer of Alacris Theranostics, as she discusses the development, application, and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) test for cancer patients. Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choices. However, deeper molecular insights are needed to […]